PAVM PAVmed Inc. - Common Stock
$4,94
Preço · Ago 19, 2026
Fundamentais a partir de Ago 13, 2026
Intervalo 52 Semanas
$0–$24
19% of range
Classificação do Analista
BUY
8 analysts
Preço-Alvo
$36
+629% upside
P/E (TTM)
-0.9
ROE
2.2%
Margem de Lucro Líquido
564.8%
PAVM Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$4.94
Capitalização de Mercado
$5M
P/E (TTM)
-0.9
EPS (TTM)
$-5.63
Receita (TTM)
$71.0K
Rendimento div.
—
ROE
2.2%
Dívida/Capital
—
Intervalo 52 Semanas
$0 – $24
PAVM Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$71.0K
2021-12-31
→
2025-12-31
EPS
$-5.63
2022-12-31
→
2025-12-31
Fluxo de caixa livre
$-5M
2020-12-31
→
2025-12-31
Margens
564.8%
2021-12-31
→
2021-12-31
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
PAVM
Mediana de Pares
P/E (TTM)
-0.9
32.9
P/S (TTM)
64.5
3.2
P/B
0.1
1.7
Price / FCF (Preço / FCF)
-0.9
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
PAVM
Mediana de Pares
Operating Margin (Margem Operacional)
-30712.7%
—
Net Profit Margin (Margem de Lucro Líquido)
564.8%
-10.7%
ROA
1.1%
-9.1%
ROE
2.2%
-8.3%
ROIC
-64.2%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
PAVM
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
0.2
1.4
Quick Ratio (Índice de Liquidez Seca)
0.1
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
PAVM
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-97.6%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-42.7%
—
Net Income YoY (Lucro Líquido Ano a Ano)
-99.0%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
PAVM
Mediana de Pares
PAVM Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
8 analistas
- Compra forte 2 25,0%
- Compra 5 62,5%
- Manter 1 12,5%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
2 analistas · 2026-08-18
Mediana
$36.00
← Abaixo de todos os alvos
$4.94
Mín
$16.00
Máx
$56.00
Alvo mediano
$36.00
+629,4%
Alvo médio
$36.00
+629,4%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
2.5%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-4.42 | $-0.71 | -3.7% |
| 31 de Dezembro de 2025 | $-5.52 | $-5.51 | -0.01% |
| 30 de Setembro de 2025 | $-8.70 | $-5.20 | -3.5% |
| 30 de Junho de 2025 | $-22.20 | $-3.98 | -18.2% |
| 31 de Março de 2025 | $10.20 | $-3.98 | 14.2% |
| 31 de Dezembro de 2024 | $8.70 | $-17.44 | 26.1% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| PAVM | $6M | -1.2 | -97.6% | 564.8% | 2.2% | — |
| SNWV | $256M | 72.8 | 35.0% | 26.8% | -395.5% | 77.1% |
| QTI | $73M | -3.0 | 287.9% | -111.4% | -688.9% | 45.4% |
| ARAY | — | -68.5 | 2.7% | -0.35% | — | 32.0% |
| MODD | $25M | -0.4 | — | — | -260.0% | — |
| BEAT | — | — | — | — | — | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $71.0K | $3M | $2M | $377.0K | $500.0K | |
| Cost of Revenue | $218.0K | $5M | $6M | $4M | $585.0K | |
| Gross Profit | · | · | · | · | $-85.0K | |
| R&D Expense | $4M | $6M | $14M | $25M | $20M | |
| SG&A Expense | $16M | $25M | $31M | $41M | $25M | |
| Operating Expenses | $22M | $47M | $71M | $91M | $55M | |
| Operating Income | $-22M | $-44M | $-69M | $-91M | $-54M | |
| Interest Income | $29.0K | $254.0K | $505.0K | $169.0K | · | |
| Other Non-op | $19M | $73M | $-10M | $-12M | $-2M | |
| Pretax Income | $-2M | $28M | $-79M | $-103M | $-56M | |
| Income Tax | $0 | $0 | · | · | · | |
| Net Income | $401.0K | $40M | $-64M | $-89M | $-50M | |
| EPS (Basic) | $-5.63 | $99.15 | $-9.16 | $-15.03 | $-0.65 | |
| EPS (Diluted) | $-5.63 | $14.90 | $-9.16 | $-15.03 | · | |
| Shares (Basic) | 670,466 | 322,407 | 7,231,546 | 5,938,406 | 77,515,767 | |
| Shares (Diluted) | 670,466 | 2,173,398 | 7,231,546 | 5,938,406 | · | |
| EBITDA | $-22M | $-43M | $-66M | $-88M | $-54M |
Balanço Patrimonial 23
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $1M | $20M | $40M | $77M | |
| Receivables | $15.0K | $18.0K | $61.0K | $17.0K | $200.0K | |
| Inventory | · | · | $278.0K | $111.0K | · | |
| Prepaid Expense | $1M | $961.0K | $5M | $4M | $5M | |
| Current Assets | $3M | $2M | $24M | $44M | $83M | |
| PP&E (Net) | $77.0K | $151.0K | $2M | $2M | $2M | |
| PP&E (Gross) | $1M | $1M | $4M | $3M | $2M | |
| Accum. Depreciation | $1M | $1M | $2M | $808.0K | $138.0K | |
| Intangibles | · | · | $1M | $3M | $2M | |
| Other Non-current Assets | $56.0K | $208.0K | $1M | $1M | $725.0K | |
| Total Assets | $39M | $31M | $33M | $54M | $87M | |
| Accounts Payable | $678.0K | $657.0K | $2M | $3M | $3M | |
| Accrued Liabilities | $2M | $5M | $7M | $4M | $4M | |
| Current Liabilities | $15M | $35M | $54M | $41M | $8M | |
| Capital Leases | $2M | $2M | $3M | $2M | · | |
| Total Liabilities | $17M | $38M | $57M | $43M | $8M | |
| Common Stock | $1.0K | $1.0K | $9.0K | $6.0K | $86.0K | |
| Paid-in Capital | $268M | $249M | $238M | $216M | $198M | |
| Retained Earnings | $-259M | $-255M | $-294M | $-228M | $-139M | |
| Treasury Stock | · | · | · | $408.0K | · | |
| Stockholders' Equity | $34M | $-2M | $-54M | $-10M | $62M | |
| Liabilities + Equity | $39M | $31M | $33M | $54M | $87M | |
| Shares Outstanding | 927,934 | 373,300 | 8,578,505 | 6,300,703 | 86,367,845 |
Fluxo de Caixa 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $105.0K | $1M | $3M | $2M | $226.0K | |
| Stock-based Comp | $2M | $6M | $11M | $20M | $15M | |
| Amort. of Intangibles | $0 | $559.0K | $2M | $2M | $146.0K | |
| Other Non-cash | $-7M | $-81M | $-2M | $-4M | · | |
| Operating Cash Flow | $-5M | $-34M | $-52M | $-71M | $-41M | |
| CapEx | $31.0K | $55.0K | $242.0K | $2M | $1M | |
| Investing Cash Flow | $-31.0K | $-16M | $758.0K | $-5M | $-4M | |
| Stock Issued | · | $2M | $2M | $79.0K | $55M | |
| Net Stock Activity | · | $2M | $2M | · | $55M | |
| Financing Cash Flow | $6M | $31M | $31M | $38M | $104M | |
| Net Change in Cash | $353.0K | $-18M | $-20M | $-38M | $60M | |
| Taxes Paid | $0 | · | · | · | · | |
| Free Cash Flow | $-5M | $-34M | $-52M | $-73M | $-42M |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | -17.0% | |
| Operating Margin | -30712.7% | -1482.9% | -2751.8% | -24118.6% | -10878.6% | |
| Net Margin | 564.8% | 1326.4% | -2567.0% | -23602.9% | -10069.4% | |
| Pretax Margin | -3477.5% | 947.6% | -3170.5% | -27384.1% | -11225.2% | |
| EBITDA Margin | -30564.8% | -1443.0% | -2634.5% | -23466.8% | -10878.6% | |
| ROA | 1.1% | 124.8% | -147.4% | -126.3% | -94.3% | |
| ROE | 2.2% | -141.3% | 202.1% | -342.3% | -158.4% | |
| ROIC | -64.2% | · | · | · | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | 0.1 | 0.5 | 1.1 | · | |
| Quick Ratio | 0.1 | 0.0 | 0.4 | 1.0 | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | 33.0 | · | · | |
| Receivables Turnover | 4.3 | 75.9 | 64.1 | 3.5 | 5.0 |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | -97.6% | 19.8% | 563.1% | -24.6% | · | |
| Revenue CAGR 3Y | -42.7% | 81.6% | · | · | · | |
| Net Income YoY | -99.0% | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $71.0K | $3M | $2M | $377.0K | $500.0K | |
| Net Income TTM | $401.0K | $40M | $-64M | $-89M | $-50M | |
| Market Cap | $6M | $7M | $35M | $680M | $3.19B | |
| P/E | -1.2 | 0.0 | -0.4 | -0.5 | · | |
| P/S | 86.7 | 2.3 | 14.1 | 1805.0 | 6373.9 | |
| P/B | 0.2 | -2.8 | -0.7 | -70.3 | 51.7 | |
| P / Tangible Book | 0.2 | · | · | · | 53.4 | |
| P / Cash Flow | -1.2 | -0.2 | -0.7 | -9.6 | -78.5 | |
| P / FCF | -1.2 | -0.2 | -0.7 | -9.4 | -75.8 | |
| Earnings Yield | -84.9% | 2372.6% | -222.3% | -208.8% | · |
Demonstração de Resultados 17
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.0K | $22.0K | $52.0K | $5.0K | $6.0K | $8.0K | $10.0K | $996.0K | $979.0K | $1M | · | $791.0K | $166.0K | $446.0K | · | $76.0K | |
| Cost of Revenue | $122.0K | $97.0K | $86.0K | $55.0K | $41.0K | $36.0K | $49.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | |
| R&D Expense | $2M | $1M | $2M | $1M | $790.0K | $787.0K | $808.0K | $2M | $2M | $2M | $4M | $3M | $3M | $4M | $6M | $6M | |
| SG&A Expense | $5M | $6M | $5M | $4M | $4M | $4M | $4M | $7M | $7M | $7M | $7M | $7M | $7M | $10M | $10M | $10M | |
| Operating Expenses | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $13M | $15M | $15M | $17M | $16M | $17M | $21M | $25M | $23M | |
| Operating Income | $-7M | $-8M | $-7M | $-5M | $-5M | $-5M | $-5M | $-12M | $-14M | $-14M | $-16M | $-16M | $-16M | $-20M | $-25M | $-23M | |
| Interest Expense | · | · | · | · | $26.0K | $26.0K | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | $10.0K | $19.0K | $3.0K | $10.0K | $8.0K | $8.0K | $2.0K | $70.0K | $110.0K | $72.0K | $97.0K | $124.0K | $163.0K | $121.0K | $106.0K | $54.0K | |
| Other Non-op | $0 | $-40.0K | $4M | $-1M | $0 | $0 | $6M | $72M | $-1M | $-4M | $-1M | $-6M | $-1M | $-2M | $29.0K | $-7M | |
| Pretax Income | $-7M | $-1M | $-3M | $-6M | $-12M | $19M | $1M | $61M | $-15M | $-19M | $-17M | $-22M | $-18M | $-22M | $-25M | $-30M | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-5M | $-60.0K | $-1M | $-5M | $-12M | $19M | $1M | $64M | $-11M | $-15M | $-14M | $-18M | $-15M | $-18M | $-20M | $-26M | |
| EPS (Basic) | $-0.87 | $-4.42 | $-5.88 | $-0.29 | $-22.08 | $38.26 | $96.53 | $6.43 | $-1.19 | $-2.62 | $-1.90 | $-2.38 | $-2.10 | $-2.78 | $-14.25 | $-0.29 | |
| EPS (Diluted) | $-0.87 | $-4.42 | $-4.94 | $-0.29 | $-22.08 | $10.10 | $17.27 | $1.44 | $-1.19 | $-2.62 | $-1.90 | $-2.38 | $-2.10 | $-2.78 | $-14.25 | $-0.29 | |
| Shares (Basic) | 6,269,384 | 1,580,788 | -52,844,898 | 21,554,546 | 602,822 | 462,539 | -27,530,695 | 10,005,379 | 9,152,819 | 8,694,904 | -13,660,870 | 7,462,751 | 6,956,655 | 6,473,010 | -257,114,300 | 89,758,927 | |
| Shares (Diluted) | 6,269,384 | 1,580,788 | -91,465,134 | 21,554,546 | 602,822 | 1,746,739 | -60,149,963 | 44,475,638 | 9,152,819 | 8,694,904 | -13,660,870 | 7,462,751 | 6,956,655 | 6,473,010 | -81,785,718 | 89,758,927 | |
| EBITDA | $-7M | $-8M | · | $-5M | $-5M | $-5M | · | $-12M | $-14M | $-13M | · | $-16M | $-16M | $-20M | · | $-23M |
Balanço Patrimonial 23
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $6M | $2M | $3M | $4M | $3M | $1M | $765.0K | $25M | $26M | $20M | $26M | $37M | $49M | $40M | $57M | |
| Receivables | $16.0K | $21.0K | $15.0K | $3.0K | $3.0K | $9.0K | $18.0K | $16.0K | $219.0K | $67.0K | $61.0K | $36.0K | $41.0K | $27.0K | $17.0K | $31.0K | |
| Inventory | · | · | · | · | · | · | · | $6.0K | $687.0K | $410.0K | $278.0K | · | · | · | $111.0K | · | |
| Prepaid Expense | $1M | $933.0K | $1M | $1M | $1M | $929.0K | $961.0K | $1M | $4M | $4M | $5M | $6M | $6M | $5M | $4M | $5M | |
| Current Assets | $5M | $7M | $3M | $4M | $5M | $4M | $2M | $2M | $30M | $30M | $24M | $32M | $43M | $54M | $44M | $62M | |
| PP&E (Net) | $73.0K | $79.0K | $77.0K | $81.0K | $100.0K | $114.0K | $151.0K | $216.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $4M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $2M | · | · | · | $808.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | $947.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | |
| Other Non-current Assets | $51.0K | $56.0K | $56.0K | $51.0K | $51.0K | $51.0K | $208.0K | $75.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Assets | $40M | $45M | $39M | $38M | $44M | $53M | $31M | $31M | $39M | $37M | $33M | $42M | $54M | $65M | $54M | $72M | |
| Accounts Payable | $1M | $983.0K | $678.0K | $342.0K | $387.0K | $369.0K | $657.0K | $465.0K | $1M | $1M | $2M | $2M | $1M | $1M | $3M | $2M | |
| Accrued Liabilities | $2M | $2M | $2M | $3M | $3M | $2M | $5M | $5M | $7M | $7M | $7M | $5M | $5M | $4M | $4M | $3M | |
| Current Liabilities | $4M | $4M | $15M | $10M | $11M | $10M | $35M | $38M | $53M | $55M | $54M | $55M | $51M | $51M | $41M | $42M | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $5M | $3M | $3M | $3M | $4M | $4M | $2M | $2M | |
| Total Liabilities | $21M | $20M | $17M | $12M | $12M | $12M | $38M | $40M | $58M | $58M | $57M | $58M | $55M | $54M | $43M | $44M | |
| Common Stock | $6.0K | $6.0K | $1.0K | $23.0K | $20.0K | $17.0K | $1.0K | $11.0K | $10.0K | $9.0K | $9.0K | $120.0K | $109.0K | $101.0K | $6.0K | $92.0K | |
| Paid-in Capital | $296M | $295M | $268M | $265M | $264M | $256M | $249M | $248M | $244M | $238M | $238M | $232M | $226M | $221M | $216M | $214M | |
| Retained Earnings | $-265M | $-259M | $-259M | $-257M | $-251M | $-237M | $-255M | $-256M | $-321M | $-310M | $-294M | $-279M | $-261M | $-246M | $-228M | $-208M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $408.0K | $408.0K | |
| Stockholders' Equity | $35M | $40M | $34M | $33M | $38M | $45M | $-2M | $-5M | $-74M | $-69M | $-54M | $-43M | $-32M | $-22M | $-10M | $9M | |
| Liabilities + Equity | $40M | $45M | $39M | $38M | $44M | $53M | $31M | $31M | $39M | $37M | $33M | $42M | $54M | $65M | $54M | $72M | |
| Shares Outstanding | 6,269,418 | 6,269,384 | 927,934 | 23,053,498 | 20,142,463 | 16,769,619 | 373,300 | 10,660,394 | 9,554,381 | 8,858,597 | 8,578,505 | 119,701,959 | 108,537,994 | 100,596,406 | 6,300,703 | 92,228,862 |
Fluxo de Caixa 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $19.0K | $20.0K | $18.0K | $22.0K | $22.0K | $43.0K | $69.0K | $238.0K | $305.0K | $586.0K | $725.0K | $733.0K | $747.0K | $727.0K | $726.0K | $700.0K | |
| Stock-based Comp | $917.0K | $182.0K | $232.0K | $383.0K | $162.0K | $930.0K | $732.0K | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | |
| Amort. of Intangibles | · | · | · | · | · | · | $0 | $82.0K | $105.0K | $372.0K | $506.0K | $505.0K | $505.0K | $505.0K | $506.0K | $505.0K | |
| Other Non-cash | · | $-3M | · | · | · | $-22M | · | · | · | $-365.0K | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-896.0K | $-1M | $-2M | $94.0K | $-9M | $-12M | $-13M | $-12M | $-11M | $-13M | $-16M | $-17M | $-19M | |
| CapEx | $13.0K | $22.0K | $14.0K | $3.0K | $8.0K | $6.0K | $4.0K | $6.0K | $3.0K | $42.0K | $183.0K | $18.0K | $15.0K | $26.0K | $298.0K | $316.0K | |
| Investing Cash Flow | $-13.0K | $-22.0K | $-14.0K | $-3.0K | $-8.0K | $-6.0K | $-4.0K | $-16M | $-3.0K | $-42.0K | $-183.0K | $-18.0K | $-15.0K | $974.0K | $-298.0K | $-1M | |
| Stock Issued | · | · | · | $0 | $0 | $841.0K | · | $284.0K | $198.0K | $786.0K | $367.0K | $0 | $609.0K | $557.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | $841.0K | · | · | · | $786.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $8M | $0 | $-2.0K | $2M | $3M | $330.0K | $284.0K | $12M | $19M | $5M | $352.0K | $684.0K | $25M | $80.0K | $12M | |
| Net Change in Cash | $-3M | $5M | $-2M | $-901.0K | $1M | $2M | $420.0K | $-25M | $-37.0K | $6M | $-7M | $-11M | $-12M | $10M | $-17M | $-8M | |
| Free Cash Flow | · | $-3M | · | · | · | $-2M | · | · | · | $-13M | · | · | · | $-16M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -21278.8% | -36522.7% | · | -96880.0% | -78583.3% | -68075.0% | · | -1157.8% | -1368.4% | -1403.6% | · | -1963.1% | -9930.1% | -4574.2% | · | · | |
| Net Margin | -16315.1% | -272.7% | · | -107660.0% | -198683.3% | 237100.0% | · | 6439.9% | -1082.7% | -1521.2% | · | -2234.0% | -8757.2% | -4020.4% | · | · | |
| Pretax Margin | -19993.9% | -4836.4% | · | -120220.0% | -205400.0% | 232787.5% | · | 6071.1% | -1491.4% | -1851.2% | · | -2749.7% | -10778.3% | -4980.7% | · | · | |
| EBITDA Margin | -21278.8% | -36431.8% | · | -96880.0% | -78583.3% | -67537.5% | · | -1157.8% | -1368.4% | -1345.0% | · | -1963.1% | -9930.1% | -4411.2% | · | · | |
| ROA | -12.8% | -0.12% | · | -15.7% | -28.6% | 42.1% | · | 177.5% | -23.3% | -29.7% | · | -30.9% | -21.4% | -24.0% | · | -45.3% | |
| ROE | -14.8% | -0.14% | · | -38.9% | 65.5% | -159.5% | · | -267.6% | 20.5% | 33.5% | · | 103.0% | 304.9% | -150.2% | · | -119.2% | |
| ROIC | -20.0% | -20.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.0 | · | 0.4 | 0.5 | 0.4 | · | 0.1 | 0.6 | 0.5 | · | 0.6 | 0.8 | 1.1 | · | 1.5 | |
| Quick Ratio | 0.9 | 1.8 | · | 0.3 | 0.4 | 0.3 | · | 0.0 | 0.5 | 0.5 | · | 0.5 | 0.7 | 1.0 | · | 1.4 | |
| Interest Coverage | · | · | · | · | -181.3 | -209.5 | · | · | · | · | · | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 49.3 | 4.9 | 8.5 | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 1.5 | · | 0.5 | 0.1 | 0.2 | · | 38.5 | 7.7 | 21.3 | · | 23.6 | 8.1 | 7.7 | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $66.0K | $41.0K | · | $1M | $2M | $3M | · | $4M | $3M | $2M | · | $1M | · | · | · | · | |
| Net Income TTM | $-23M | $2M | · | $66M | $61M | $57M | · | $21M | $-58M | $-65M | · | $-76M | $-84M | $-86M | · | $-81M | |
| Market Cap | $37M | $64M | · | $10M | $12M | $12M | · | $13M | $8M | $19M | · | $530M | $664M | $564M | · | $1.19B | |
| P/E | -0.2 | 2.2 | · | 0.6 | -4.0 | -0.4 | · | -0.3 | -0.1 | -0.2 | · | -0.6 | -1.1 | · | · | · | |
| P/S | 564.2 | 1552.1 | · | 9.8 | 6.1 | 4.0 | · | 3.5 | 2.6 | 7.9 | · | 358.1 | · | · | · | · | |
| P/B | 1.1 | 1.6 | · | 0.3 | 0.3 | 0.3 | · | -2.7 | -0.1 | -0.3 | · | -12.2 | -21.1 | -25.6 | · | 133.0 | |
| P / Tangible Book | 1.1 | 1.6 | · | 0.3 | 0.3 | 0.3 | · | · | · | · | · | · | · | · | · | 238.0 | |
| P / Cash Flow | · | -24.3 | · | · | · | -7.6 | · | · | · | -1.4 | · | · | · | -34.7 | · | · | |
| P / FCF | · | -24.1 | · | · | · | -7.6 | · | · | · | -1.4 | · | · | · | -34.6 | · | · | |
| Earnings Yield | -465.7% | 45.8% | · | 174.0% | -25.0% | -281.6% | · | -386.2% | -1017.2% | -461.7% | · | -170.6% | -89.2% | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $71.0K | $3M | $2M | $377.0K | $500.0K |
| Margem Bruta % | — | — | — | — | -17.0% |
| Margem Operacional % | -30712.7% | -1482.9% | -2751.8% | -24118.6% | -10878.6% |
| Lucro líquido | $401.0K | $40M | $-64M | $-89M | $-50M |
| EPS Diluído | $-5.63 | $14.90 | $-9.16 | $-15.03 | — |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 0.2 | 0.1 | 0.5 | 1.1 | — |
| Índice de Liquidez Seca | 0.1 | 0.0 | 0.4 | 1.0 | — |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-5M | $-34M | $-52M | $-73M | $-42M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 24 declarantes · $5.5M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 7 (-11 vs trimestre anterior) | 5 (-7 vs trimestre anterior) | 4 (+4 vs trimestre anterior) | 3 (0 vs trimestre anterior) | +401K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
Executivos da empresa 19 insiders · 7 diretores · 10 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Aklog Lishan | Chairman and CEO | 2 de Abril de 2026 A | 357.614 | 0 | 0 | $0 |
| Dennis M Mcgrath | President and CFO | 2 de Abril de 2026 A | 186.695 | 0 | 0 | $0 |
| Richard F Fitzgerald | CFO and Secretary | 1 de Junho de 2016 A | 200 | 0 | 0 | $0 |
| Shaun O'Neil | Chief Operating Officer | 2 de Abril de 2026 A | 115.598 | 0 | 0 | $0 |
| Victoria Tou-Ho Lee | Chief Medical Officer | 2 de Abril de 2026 A | 71.666 | 0 | 0 | $0 |
| Michael Adam Gordon | General Counsel | 2 de Abril de 2026 A | 115.000 | 0 | 0 | $0 |
| Brian J. Deguzman | Chief Medical Officer | 18 de Fevereiro de 2022 A | 0 | 0 | 0 | $0 |
| Timothy E Baxter | Conselheiro | 2 de Abril de 2026 A | 21.097 | 0 | 0 | $0 |
| Debra White | Conselheiro | 2 de Abril de 2026 A | 21.097 | 0 | 0 | $0 |
| Sundeep Agrawal | Conselheiro | 2 de Abril de 2026 A | 19.337 | 0 | 0 | $0 |
| Michael J Glennon | Conselheiro | 2 de Abril de 2026 A | 21.653 | 0 | 0 | $0 |
| Ronald M Sparks | Conselheiro | 2 de Abril de 2026 A | 21.097 | 0 | 0 | $0 |
| Joan B Harvey | Conselheiro | 22 de Fevereiro de 2024 A | 65.000 | 0 | 0 | $0 |
| James L Cox | Conselheiro | 22 de Fevereiro de 2024 A | 65.000 | 0 | 0 | $0 |
| David S. Battleman | Conselheiro | 1 de Abril de 2021 A | — | 0 | 0 | $0 |
| Joshua R Lamstein | Conselheiro | 21 de Dezembro de 2017 J | 163.177 | 0 | 0 | $0 |
| Matthew Sirovich | Detentor de 10% | 25 de Novembro de 2020 S | 1.027.744 | 0 | 0 | $0 |
| Ira Scott Greenspan | Detentor de 10% | 8 de Junho de 2018 S | 421.691 | 0 | 0 | $0 |
| Iv David Weild | — | 1 de Abril de 2021 A | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 4 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Aklog Lishan | 9 de Abril de 2026 | 5,10% | Declaração inicial | Investimento passivo | SEC |
| Lishan Aklog, M.D., Pavilion Venture Partners LLC | 6 de Julho de 2018 | — | Declaração inicial | Investimento passivo | SEC |
| Ira Scott Greenspan ×3 declarações | 6 de Julho de 2018 | — | Declaração inicial | — | SEC |
| Lishan Aklog, Pavilion Venture Partners LLC, HCFP/Capital Partners III LLC ×3 declarações | 26 de Abril de 2018 | — | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 2 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.